Skip to main content
Medexus Pharmaceuticals Inc. logo

Medexus Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · MDP ISIN · CA58410Q2036 LEI · 8945002TBEYY0HLH1M19 TSX Manufacturing
Filings indexed 638 across all filing types
Latest filing 2021-07-29 Regulatory Filings
Country CA Canada
Listing TSX MDP

About Medexus Pharmaceuticals Inc.

https://www.medexus.com/en_US

Medexus Pharmaceuticals, Inc. is an innovative specialty pharmaceutical company engaged in the development and commercialization of treatment solutions. The company utilizes a highly scalable North American business model, leveraging a fully integrated infrastructure encompassing commercial operations, supply chain, regulatory affairs, and a dedicated salesforce. Medexus focuses on building a portfolio of specialty and rare disease products across key therapeutic areas, including hematology, hematology-oncology, allergy, dermatology, and rheumatology. Its mission is to deliver quality healthcare products to patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Consent letter of issuer's legal counsel.pdf
Regulatory Filings Classification · 95% confidence The document is a letter of consent from a law firm regarding references to their name and legal opinions in a Final Short Form Base Shelf Prospectus dated July 28, 2021. It is addressed to multiple securities commissions and confirms no misrepresentations in the prospectus. The document does not contain financial statements or detailed financial data but is related to a regulatory filing for a securities offering. The document length is short (1701 characters) and is primarily a legal consent letter, not the prospectus itself. Therefore, it fits best under Regulatory Filings (RNS) as it is a compliance-related filing rather than a full report or announcement of financial results.
2021-07-29 English
Auditors' consent letter.pdf
Regulatory Filings Classification · 95% confidence The document is a consent letter from the auditor (PricewaterhouseCoopers LLP) regarding the use of their audit report in a short form base shelf prospectus dated July 28, 2021. It references the consolidated financial statements audited for the years ended March 31, 2021 and 2020. The document explicitly states it is not an audit or review of the prospectus itself but a consent to the use of the auditor's report in the prospectus. The document length is short (2697 characters) and it does not contain actual financial statements or substantive financial data, only a consent statement. Therefore, this is not the audit report itself nor the annual report but a regulatory filing related to the audit report's use in a financing document. According to the rules, such auditor consents are classified as Regulatory Filings (RNS).
2021-07-29 English
Non-issuer's submission to jurisdiction and appointment of agent.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Non-Issuer Form of Submission to Jurisdiction and Appointment of Agent for Service of Process' and references National Instrument 41-101, which relates to prospectus requirements and securities distribution. It contains details about the issuer, filing person, agent for service of process, and legal jurisdiction for proceedings related to securities distribution. There are no financial statements, earnings data, or management discussion. The document is a legal filing related to securities regulation and appointment of an agent for service of process, not a financial report or announcement of financial results. It does not fit into categories like Annual Report, Earnings Release, or Capital/Financing Update. It is a regulatory compliance filing related to securities law. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length is under 5,000 characters and contains substantive legal content, not a mere announcement, so it is not Report Publication Announcement (RPA).
2021-07-29 English
Non-issuer's submission to jurisdiction and appointment of agent.pdf
Regulatory Filings Classification · 100% confidence The document is titled 'Appendix C to National Instrument 41-101 General Prospectus Requirements' and is a 'Non-Issuer Form of Submission to Jurisdiction and Appointment of Agent for Service of Process.' It contains details about the issuer, filing person, agent for service of process, and legal jurisdiction related to securities distribution under a prospectus dated July 28, 2021. There are no financial statements, earnings data, management discussion, or other typical financial report content. The document is a regulatory form related to legal and jurisdictional appointment for securities distribution, not a financial report or announcement of financial results. It fits best under Regulatory Filings (RNS) as a compliance document that does not fit other specific categories.
2021-07-29 English
Decision Document (Preliminary).PDF
Regulatory Filings Classification · 95% confidence The document is a receipt from the Ontario Securities Commission for the filing of a Preliminary Base Shelf Prospectus dated July 20, 2021. It is a regulatory acknowledgment of a filing rather than the filing itself. The document is short (1072 characters) and serves as confirmation of receipt, not containing financial data or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and confirmations.
2021-07-21 English
Annual MD&A - French.pdf
Management Reports Classification · 95% confidence The document is titled "Rapport de gestion" which translates to "Management Report" and covers the quarter and fiscal year ended March 31, 2021. It includes detailed financial highlights, discussion of financial measures, acquisition impacts, and forward-looking statements. The text references management's interpretation and analysis of financial results, business trends, and outlook. It is not merely an announcement or a brief summary but a comprehensive report with substantive financial data and management commentary. Therefore, it fits the category of Management Reports (MDA). The document length (15,000 characters) and content confirm it is a full report, not just an announcement or certification.
2021-07-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.